Novartis CEO opens door to cancer patient demanding ‘fair’ CAR-T pricing
admin 21st August 2017 Uncategorised 0Cancer patient David Mitchell is so concerned about the potentially high price of CAR-T treatments that he requested a meeting with Joe Jimenez, CEO of Novartis, as the company works to establish a price for its upcoming product in this new class.
More: Novartis CEO opens door to cancer patient demanding ‘fair’ CAR-T pricing
Source: fierce